Table 1. Categorization of Reports about Control of MDROs in Healthcare Settings, 1982-2005

MDRO	MDR-GNB	MRSA	VRE
No. of Studies Reviewed/category	30	35	39

 Top of Page

Types of Healthcare Facilities from which Study or Report Arose

Facility Type	MDR-GNB	MRSA	VRE
No. (%) from academic facilities α	30 (100)	28 (80)	33 (85)
No. (%) from other hospitals	0	4 (11)	3 (8)
No. (%) from LTCFs	0	1 (3)	2 (5)
No. (%) from multiple facilities in a region	0	2 (6)	1 (2)

α Variably described as university hospitals, medical school affiliated hospitals, VA teaching hospitals, and, to a much lesser extent, community teaching hospitals

 Top of Page

Unit of Study for MDRO Control Efforts

Unit of Study	MDR-GNB	MRSA	VRE
Special unit β	20	13	19
Hospital	10	19	17
LTCF	0	1	2
Region	0	2	1

β Includes intensive care units, burn units, dialysis units, hematology/oncology units, neonatal units, neonatal intensive care units, and, in a few instances, individual wards of a hospital

 Top of Page

Nature of Study or Report on MDRO Control χ

Nature of Study	MDR-GNB	MRSA	VRE
Outbreak	22	19	28
Non-outbreak	8	16	11

χ Based on authors’ description – if they called their experience an outbreak or not; authors vary in use of term so there is probable overlap between two categories

 Top of Page

Total Period of Observation after Interventions Introduced

Time Period	MDR-GNB	MRSA	VRE
Less than 1 year	17	14	25
1-2 years	6	6	6
2-5 years	5	11	8
Greater than 5 years	2	4

 Top of Page

Numbers of Control Measures Employed in Outbreaks/Studies

Outbreak Control Measures	MDR-GNB	MRSA	VRE
Range	2-12	0-11	1-12
Median	7	7	8
Mode	8	7	9

References for Tables

MDR-GNBs: (6, 8, 9, 11, 16, 38, 174, 175, 180, 209, 210, 213-215, 218, 334, 388, 406, 407)

MRSA: (68, 89, 152, 153, 165-173, 183, 188, 194, 204, 205, 208, 240, 269, 279, 280, 289, 304,
312, 327, 365, 392, 397, 408-412)

 Top of Page